Logo Image
News
All NewsFDA UpdatesPress Releases
Watch
Expert ConversationsNews & AnalysisShows & PodcastsSponsored Webcast
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsMicrositesPartnersPulsePointSponsoredWhiteboards

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Genitourinary Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Rachel L. Brown, PharmD, MPH

Advertisement

Articles by Rachel L. Brown, PharmD, MPH

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

ByJeffrey C. Lombardo, PharmD, BCOP,Rachel L. Brown, PharmD, MPH
May 24th 2018

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

ByJeffrey C. Lombardo, PharmD, BCOP,Rachel L. Brown, PharmD, MPH
February 22nd 2018

Continuing education activity featured in the March 2018 edition of Pharmacy Times.

The Importance of Consistency and Compliance to Meet the Increasing Demand for Nonsterile Compounding

ByLoyd V. Allen, Jr, BS, MS, PhD,Rachel L. Brown, PharmD, MPH
November 24th 2017
Advertisement

Latest Updated Articles

  • The Importance of Consistency and Compliance to Meet the Increasing Demand for Nonsterile Compounding
    The Importance of Consistency and Compliance to Meet the Increasing Demand for Nonsterile Compounding

    November 24th 2017

  • Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs
    Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

    February 22nd 2018

  • Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs
    Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

    May 24th 2018



Advertisement
Advertisement

Trending on Pharmacy Times

1

Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma

2

FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth

3

Fentanyl-Responsive Microneedle Patch Automatically Releases Naloxone in Preclinical Study

4

Delegating to Technicians: The Key to Pharmacists Practicing at Top of License

5

The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us